Iprazochrome

Revision as of 18:26, 10 February 2014 by Pratik Bahekar (talk | contribs)
Jump to navigation Jump to search


Template:Oxetoron Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information, click here.

Iprazochrome
File:Iprazochrome.png
Clinical data
Synonyms[(3-hydroxy-1-isopropyl-6-oxo-2,3-dihydroindol-5-ylidene)amino]urea
AHFS/Drugs.comInternational Drug Names
Pregnancy
category
  • AU: <! -- A / B1 / B2 / B3 / C / D / X -->
  • US: <! -- A / B / C / D / X-- >
ATC code
Legal status
Legal status
  • AU: <! -- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
  • CA: <! -- Schedule I, II, III, IV, V, VI, VII, VIII-- >
  • UK: <! -- GSL, P, POM, CD, or Class A, B, C-- >
  • US: <! -- OTC / Rx-only / Schedule I, II, III, IV, V-- >
Identifiers
CAS Number
PubChem CID
UNII
KEGG
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC12H16N4O3
Molar mass264.28 g/mol
3D model (JSmol)
  (verify)

Iprazochrome is an antimigraine agent.

It is a serotonin antagonist.[1]

References

  1. Hampf G (1989). "Effect of serotonin antagonists on patients with atypical facial pain". J Craniomandib Disord. 3 (4): 211–2. PMID 2639158.


Template:Antimigraine preparations